C16 | Risk factors for recent HIV infection in Zambia, 2020 | E-poster | Novel methods/algorithms for detecting acute and recent HIV infections |
C18 | Using multiplex assay to detect HIV-1, HIV-2 and recent HIV-1 infection in Nigeria | E-poster | Novel studies to measure HIV incidence |
C18 | A novel tool to estimate HIV-incidence in mothers living in resource-limited settings | E-poster | Novel studies to measure HIV incidence |
C18 | HIV incidence in postpartum period: findings from Uganda's national PMTCT Impact Evaluation (PMTCT-IE) 2017-2019 | E-poster | Novel studies to measure HIV incidence |
A36 | Immunogens based on VLPs presenting epitopes of the HIV-1 fusion peptide | On-demand oral abstract session | Novel vectors and strategies |
A36 | Reactivity of plasma from HIV-infected pregnant women with recombinant Q β phages displaying the membrane proximal external region of HIV-1 envelope | E-poster | Novel vectors and strategies |
A36 | A new, globally appropriate rapid vaccine production platform: killed whole cell genome-reduced bacterial vaccine with surface-expressed antigen: applications to coronavirus and HIV fusion peptides | E-poster | Novel vectors and strategies |
B49 | Food rescue programs in food-insecure PWLH in Baylor Mwanza-Tanzania: a descriptive study | E-poster | Nutrition |
D10 | CUSTOMIZE: overall results from a hybrid III implementation-effectiveness study examining implementation of cabotegravir and rilpivirine long-acting injectable for HIV treatment in US healthcare settings; final patient and provider data | On-demand oral abstract session | Operational challenges in implementing HIV services |
D10 | Access to maternal health and prevention of mother-to-child HIV transmission services during the COVID-19 era in sub-Saharan Africa | E-poster | Operational challenges in implementing HIV services |